Find More Contacts for Proxygen
Protected Content
Non-Management Operations
1 email found
View contacts for Proxygen to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Company Type For Profit
  • Contact Email office@proxygen.com
  • Phone Number +43 (0)1 226 1030

Proxygen is reshaping the druggable space. Their company harnesses technology and know-how to exploit this potential, thereby redefining the borders of the druggable target space. They developed rational discovery assays that, for the first time, enabled the identification and development of novel glue degraders at scale, putting them at the

forefront of charting this unexplored chemical space.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Biotechnology Companies With More Than $1M in Revenue (Top 10K)
9,992 Number of Organizations • $811.3B Total Funding Amount • 37,619 Number of Investors
Life Science Companies With More Than 50 Employees
1,768 Number of Organizations • $124.8B Total Funding Amount • 3,954 Number of Investors
Life Science Companies
8,230 Number of Organizations • $165.9B Total Funding Amount • 11,220 Number of Investors
Life Science Companies With Less Than $50M in Revenue
4,434 Number of Organizations • $74.5B Total Funding Amount • 7,949 Number of Investors

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Proxygen's headquarters? Proxygen is located in Vienna, Wien, Austria.Who invested in Proxygen? Proxygen is funded by Boehringer Ingelheim.When was the last funding round for Proxygen? Proxygen closed its last funding round on Jul 31, 2020 from a Grant round.Who are Proxygen's competitors? Alternatives and possible competitors to Proxygen may include Bright Peak Therapeutics, Numab, and Apogenix.